Filter posts

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …

#BIO2017: A Peek at Partnering | SPARK

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring you …

California’s Transparency Bill Misses the Mark

Under a pending bill in California, drug companies would be required to disclose confidential and …

#BIO2017: A Peek at Partnering | UC Berkeley

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring you …

Insurers Still Spreading Falsehoods To Protect Their Bottom Line

For the better part of a year, BIO has been on a mission to shine …

Celebrate International Beer Day with Biotech!

On the first Friday of every August, bars, restaurants, beer lovers and pubs all over …

BIO International Convention Kickoff Event Highlights Bay Area’s Strong Bioscience Sector & Jo...

With just 90 days to go before the ribbon is cut at the BIO International …

Sara Radcliffe: Legislature Shouldn't Put Hurdles in Way of Cancer Treatments

Check out California Life Sciences Association (CLSA) president and chief executive officer Sara Radcliffe’s op-ed …